The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| INDV | +175.55% | +273.93% | +30.17% | +144% |
| S&P | +18.13% | +110.72% | +16.08% | +230% |
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $302.00M | 1.0% |
| Gross Profit | $250.00M | 36.6% |
| Gross Margin | 82.78% | 21.6% |
| Market Cap | $1.84B | -14.9% |
| Market Cap / Employee | $1.75M | 0.0% |
| Employees | 1.1K | -9.7% |
| Net Income | $18.00M | 116.8% |
| EBITDA | $74.00M | 23.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $510.00M | 68.9% |
| Accounts Receivable | $240.00M | -7.3% |
| Inventory | 149 | -12.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $337.00M | 25.7% |
| Short Term Debt | $29.00M | 123.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.96% | 14.6% |
| Return On Invested Capital | -75.35% | -77.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $148.38M | 76.8% |
| Operating Free Cash Flow | $166.04M | 88.9% |
| Metric | Q4 2023 | Q1 2024 | Q2 2025 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 872.57 | 516.14 | 20.80 | - | |
| Price to Book | -7.57 | -9.64 | -3.42 | -6.46 | -102.95% |
| Price to Sales | 1.10 | 1.31 | 1.02 | 1.58 | -16.45% |
| Price to Tangible Book Value | -3.54 | -4.51 | -3.37 | -6.31 | -36.63% |
| Price to Free Cash Flow TTM | 221.31 | 8.89 | 9.36 | - | |
| Enterprise Value to EBITDA | 17.24 | 16.15 | 16.28 | 23.15 | -33.08% |
| Free Cash Flow Yield | 0.5% | 11.3% | 10.7% | - | |
| Return on Equity | 7.8% | 12.2% | - | ||
| Total Debt | $284.00M | $375.00M | $370.00M | $366.00M | 30.25% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
